| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |